Suraj Kannan (@thesurajkannan) 's Twitter Profile
Suraj Kannan

@thesurajkannan

IM resident @ JHH (Barker 🐕). MD, PhD from JHU (Nathans college alum). Love cards, hate cardio. Opinions too dumb to be anyone else's. Down w the journalarchy.

ID: 1096460812376596480

calendar_today15-02-2019 17:26:43

3,3K Tweet

738 Followers

830 Following

Suraj Kannan (@thesurajkannan) 's Twitter Profile Photo

Haven't read it all the way and have many questions but for now I'll just say "si si I'm very intrigued" biorxiv.org/content/10.110…

Suraj Kannan (@thesurajkannan) 's Twitter Profile Photo

I feel like even with all the trials, there's a high degree of belief in the power of revasc for angina in stable cad. Honest question... is it actually beneficial and where does that data come from? The only sham trial I know of is orbita 2.

Suraj Kannan (@thesurajkannan) 's Twitter Profile Photo

I really gotta thank my residency mentors making me intentionally stage every HF patient. Trials and guidelines clearly stratify GDMT by stage based on availability of evidence - I don't think it's immediate four-pillar GDMT for everyone.

Suraj Kannan (@thesurajkannan) 's Twitter Profile Photo

Interesting take on the bucindolol trial, which is probably one of more perplexing HF trials. But surely our modern data can test this hypothesis a bit? Are sicker (but not decompensated) HF patients doing worse w beta blockade? cardiologytrials.substack.com/p/review-of-th…

Suraj Kannan (@thesurajkannan) 's Twitter Profile Photo

Now a question I need to read more about - why do we treat acute myocarditis with LV dysfunction/HF like chronic HF (e.g. w gdmt) and not like MI c/b LV dysfunction (where those medications by and large don't have as much benefit)?

Suraj Kannan (@thesurajkannan) 's Twitter Profile Photo

Also today i got asked which attending inspired my hatred of dopamine and the answer is that Josh Farkas emcrit table that says "uses for dopamine: zombie apocalypse (can't get anything better)"

Suraj Kannan (@thesurajkannan) 's Twitter Profile Photo

I mean, kinda applies for the whole field. I mean look, I obvi like sc-omics, but it's funny you have a tool where it feels like more papers have been written trying to make it useful than have been actually using it usefully

Suraj Kannan (@thesurajkannan) 's Twitter Profile Photo

jamanetwork.com/journals/jamai… I'm always down for a good juicy hot take but what about woscops? Or fame 3? I'm guessing those are looped into the cited meta-analyses, but what is the criticism of those trials on their own?

Suraj Kannan (@thesurajkannan) 's Twitter Profile Photo

I think anyone who has worked in an ICU has felt this. We ofc always fight to give everyone a chance, and especially so if their family wants it, but sometimes you really wonder about the value of what you're doing...

Suraj Kannan (@thesurajkannan) 's Twitter Profile Photo

Reading replies, I see that so many ppl think sdm means "patient has to make entire decision" Funny enough, my plumber seemed to intuitively understand sdm - he'd lay out the options, hear out my questions, tell me what he'd do, and adjust based on my preferences.